PL4055191T3 - Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi - Google Patents
Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwiInfo
- Publication number
- PL4055191T3 PL4055191T3 PL20800688.2T PL20800688T PL4055191T3 PL 4055191 T3 PL4055191 T3 PL 4055191T3 PL 20800688 T PL20800688 T PL 20800688T PL 4055191 T3 PL4055191 T3 PL 4055191T3
- Authority
- PL
- Poland
- Prior art keywords
- biomarkers
- blood
- bipolar disorder
- differential diagnosis
- depressive disorders
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Wood Science & Technology (AREA)
- Data Mining & Analysis (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Microbiology (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19208126.3A EP3819387A1 (en) | 2019-11-08 | 2019-11-08 | Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers |
| PCT/EP2020/081459 WO2021089866A1 (en) | 2019-11-08 | 2020-11-09 | Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL4055191T3 true PL4055191T3 (pl) | 2024-12-16 |
| PL4055191T4 PL4055191T4 (pl) | 2024-12-16 |
Family
ID=68501512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20800688.2T PL4055191T4 (pl) | 2019-11-08 | 2020-11-09 | Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230272472A1 (pl) |
| EP (2) | EP3819387A1 (pl) |
| JP (1) | JP2023500847A (pl) |
| KR (1) | KR20220094201A (pl) |
| CN (1) | CN114945686A (pl) |
| CA (1) | CA3155693A1 (pl) |
| ES (1) | ES2992208T3 (pl) |
| IL (1) | IL292588A (pl) |
| PL (1) | PL4055191T4 (pl) |
| WO (1) | WO2021089866A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3819386A1 (en) * | 2019-11-08 | 2021-05-12 | Alcediag | Diagnosing of mood disorders using blood rna editing biomarkers |
| CN113604583B (zh) * | 2021-08-10 | 2024-04-02 | 河南省畜牧总站 | 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒 |
| US20260053406A1 (en) * | 2022-08-14 | 2026-02-26 | Carmel Haifa University Economic Corporation Ltd. | System and method of predicting disposition of a mental disorder of a subject |
| KR102808802B1 (ko) * | 2022-09-02 | 2025-05-21 | 주식회사 비욘드디엑스 | 우울증과 양극성 장애 구분용 바이오마커 및 이의 용도 |
| EP4389915A1 (en) | 2022-12-21 | 2024-06-26 | Alcediag | Differential diagnosing of bipolar versus unipolar disorder in patient during depression phases using a to i rna editing znf267 gene |
| CN120883057A (zh) * | 2024-02-29 | 2025-10-31 | 百越达析 | 用于区分抑郁症和双相情感障碍的生物标志物及其用途 |
| WO2025233372A1 (en) * | 2024-05-06 | 2025-11-13 | Alcediag | Method for differentiating patients across healthy control, bipolar disorder, schizophrenia, and schizoaffective groups |
| CN121041412A (zh) * | 2024-05-30 | 2025-12-02 | 上海交通大学 | 细胞因子cxcl10在抑郁和/或焦虑障碍中的应用 |
| CN119724545B (zh) * | 2024-12-05 | 2025-09-23 | 南京利康医药科技有限公司 | 一种基于靶向代谢组学和机器学习模型的抑郁症疾病管理系统 |
| CN119662807B (zh) * | 2025-01-14 | 2025-11-28 | 江南大学 | 肺炎支原体肺炎感染重症度及并发症标记物及其在制备肺炎支原体感染诊断试剂盒中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1766077T3 (da) * | 2004-06-21 | 2012-07-16 | Univ Leland Stanford Junior | Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse |
| WO2008066769A2 (en) * | 2006-11-29 | 2008-06-05 | Lohocla Research Corporation | Genetic diagnosis of depression |
| EP2162550B1 (en) * | 2007-06-13 | 2017-08-09 | Alcediag | Peripherical tissue sample containing cells expressing the 5htr2c and/or adars as markers of the alteration of the mechanism of the 5htr2c mrna editing and its applications |
| CN108779494B (zh) * | 2016-03-11 | 2024-05-14 | 阿利瑟迪亚格公司 | 选择由活性化合物诱导的特定效应的基于rna编辑的算法和体外方法 |
| US11104953B2 (en) * | 2016-05-13 | 2021-08-31 | Children's Hospital Medical Center | Septic shock endotyping strategy and mortality risk for clinical application |
| AU2017302132A1 (en) * | 2016-07-28 | 2019-02-21 | Alcediag | RNA editing as biomarkers for mood disorders test |
| EP3819386A1 (en) * | 2019-11-08 | 2021-05-12 | Alcediag | Diagnosing of mood disorders using blood rna editing biomarkers |
-
2019
- 2019-11-08 EP EP19208126.3A patent/EP3819387A1/en not_active Withdrawn
-
2020
- 2020-11-09 PL PL20800688.2T patent/PL4055191T4/pl unknown
- 2020-11-09 EP EP20800688.2A patent/EP4055191B1/en active Active
- 2020-11-09 CA CA3155693A patent/CA3155693A1/en active Pending
- 2020-11-09 ES ES20800688T patent/ES2992208T3/es active Active
- 2020-11-09 US US17/774,752 patent/US20230272472A1/en active Pending
- 2020-11-09 IL IL292588A patent/IL292588A/en unknown
- 2020-11-09 CN CN202080075226.1A patent/CN114945686A/zh active Pending
- 2020-11-09 WO PCT/EP2020/081459 patent/WO2021089866A1/en not_active Ceased
- 2020-11-09 KR KR1020227016938A patent/KR20220094201A/ko active Pending
- 2020-11-09 JP JP2022525365A patent/JP2023500847A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220094201A (ko) | 2022-07-05 |
| ES2992208T3 (es) | 2024-12-10 |
| EP4055191C0 (en) | 2024-07-03 |
| EP3819387A1 (en) | 2021-05-12 |
| CN114945686A (zh) | 2022-08-26 |
| JP2023500847A (ja) | 2023-01-11 |
| WO2021089866A1 (en) | 2021-05-14 |
| EP4055191B1 (en) | 2024-07-03 |
| US20230272472A1 (en) | 2023-08-31 |
| PL4055191T4 (pl) | 2024-12-16 |
| EP4055191A1 (en) | 2022-09-14 |
| CA3155693A1 (en) | 2021-05-14 |
| IL292588A (en) | 2022-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4055191T4 (pl) | Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi | |
| PL4055190T4 (pl) | Diagnozowanie zaburzeń nastroju za pomocą biomarkerów edycji rna we krwi | |
| IL282233A (en) | Nucleic acid constructs and methods of use | |
| UY33826A (es) | Proteínas de unión con dominios trivariables y sus usos | |
| HRP20260212T1 (hr) | Pripravci i postupci za liječenje mišićne distrofije | |
| IL283149A (en) | 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer | |
| IL261002A (en) | Vcn enhancer compositions and methods of using the same | |
| EP2971132A4 (en) | FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER | |
| MA43980A (fr) | Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires | |
| EP3921445A4 (en) | DETECTION OF CANCER, ORIGIN CANCER TISSUE, AND/OR A CANCER CELL TYPE | |
| EP3411505A4 (en) | EVIDENCE OF CANCER DEVELOPMENT AND DIAGNOSTICS | |
| IL286481A (en) | Pyridazinones and methods of use thereof | |
| EP3684954C0 (en) | NON-INVASIVE DIAGNOSIS OF NON-ALCOHOLIC HEPATIC STEATOSE, NON-ALCOHOLIC STEATOHEPATITIS AND/OR LIVER FIBROSIS | |
| EP3490677A4 (en) | LIPID, PROTEIN AND METABOLITE MARKER FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | |
| EP3538135A4 (en) | POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES | |
| EP3714064C0 (en) | METHODS AND KITS FOR DOUBLE-STRANDED DNA AMPLIFICATION | |
| EP3997242A4 (en) | Methods of detecting disease and treatment response in cfdna | |
| EP4011441A4 (en) | Method for increasing blood flow and metabolic rate of eye fundus | |
| ATE520032T1 (de) | Differentielle cytokinexpression bei einer menschlichen krebserkrankung | |
| IL290297A (en) | Modified cytotoxic t cells and methods of use thereof | |
| EP3740590A4 (en) | LUNG CANCER DIAGNOSIS KITS AND METHODS | |
| IL284885A (en) | Method of characterization of visible and/or sub-visible particles in biologics | |
| EP3679147C0 (en) | 2-O-SULFATION ENZYME MUTANT AND 3-O-SULFATION ENZYME MUTANT, AND METHOD OF USE THEREOF | |
| DK3417074T3 (da) | Analytiske fremgangsmåder og arrays til bestemmelse af den hudsensibiliserende virkning af midler in vitro | |
| EP3885761C0 (en) | BIOSENSOR AND MEASURING METHOD USING SAME |